Inhibikase Therapeutics IKT Revenue Breakdown

NASDAQ IKT
$1.93 -0.13 (-6.08%)
At close: Oct 1, 2026 · 4:00 PM EDT
No revenue breakdown for IKT Inhibikase Therapeutics does not report revenue split by segment, product or geography.